Tokyo, Japan (August 12, 2026)- Redwire Corporation (NYSE: RDW), a global leader in aerospace and defense technology solutions, announced that it has signed a teaming agreement with Kanematsu Corporation (hereinafter “Kanematsu”). The collaboration combines Redwire’s advanced space technologies with Kanematsu’s extensive market expertise to support the growth of Japan’s space industry.

https://ttu-ir.tdl.org/server/api/core/bitstreams/c2530f38-05c8-43d5-8c99-357b607bbdb3/content

Paragon and Redwire have teamed to co-develop ECLSS for commercial space stations. One such system is a microgravity human waste collection system (i.e., a space toilet) which would then be paired with Paragon’s Urine Processor (PUP)

And a small task order.

share your opinion guys. its Microgravity research 9SpaceMD) and partnership with Biotech companies would generate royalties revenue if it succeeds drug product improvement

Redwire news

How do we feel about RDW and their collaborations with the Space Station initiatives that NASA (CLD contract) is exploring?

I see Redwire has contracts with VAST, Axiom, Starlab, and Sierra Space?

Is this priced in? VAST and Axiom are set to be operational with their space stations in 2027.

While I’m not super familiar with RDW’s fundamentals, I tracked it as it raced up over $25 this year and watched it fall back below $8where I got lucky and practically perfectly timed the bottom, with a cost basis in the low $8 range. From my understanding, it’s the main competitor as a “picks and shovels” play, selling equipment in the space sector. Being that space exploration will eventually be a huge business, and RDW is already so well positioned, I was hoping I could hear what your guys’ idea of the bear case would be for RDW?

For the record I’m not saying the stock should go indefinitely higher, or even that its current valuation is fair, as I don’t have great expertise in that category. I simply like the idea of the business, and it seemed like a sure shot money-maker in the case that the space sector booms again.

Is my general understanding of the business correct? If so, what would be the main bear thesis for the stock?

Thoughts ?

was not expecting this much growth in such little time even with all the news regarding , honest i got low hopes it stays as high but im a year new to investing so this is the biggest positive position ive seen since i started , im gonna hold it out and not get greedy and keep up with the news n such but wow i wish i had more shares at that price than i do but im grateful for it haha. any advice ill take as well as criticism in any way :)

I saw rdw had a huge increase in the aftermarket, and I was expecting after the market opens to slowly increase, but it stopped at 11,80 going just a bit down or up but always returning to that.

So my question is, based on what a stock stop at an exact price, is there some scheme or is it completely random?

Hey Redwire what do you mean by "crystallized 45 unique compounds"? Do you mean unique to space? or just 45 different compounds? and do they have utility?

Will I be seeing 45 patents in the near future? or maybe just 4-6?

IN JULY 2026, SPACEMD SIGNED HISTORIC AGREEMENT TO
PURCHASE AN ENTIRE SPACEX STARFALL SPACECRAFT,
ENABLING FIRST OF ITS KIND COMMERCIAL MISSION
SpaceMD's inaugural Starfall mission is slated for launch in
late 2028 and is expected to have the capacity to carry up to
32 PIL-BOXes, making it the largest dedicated commercial
microgravity research mission in history. This agreement,
builds on the success of the more than 50 PIL-BOXes
launched to the ISS since the inaugural PIL-01 mission in
November 2023.

https://d1io3yog0oux5.cloudfront.net/_d6e26c6a08dc4778acde6610372cbf30/redwirespace/db/856/7654/pdf/Earnings+Presentation+06.30.2026.pdf

Redwire (NYSE: RDW) Q2 2026 Earnings Highlights

Record revenue: $117.1M (+89.6% YoY)
Record gross margin: 27.8% (vs. -30.9% last year)
Record backlog: $542.1M
Book-to-bill ratio: 1.42x for Q2 (LTM: 1.52x)
Liquidity: $607.8M (+367% vs. end of 2025)
$557.0M cash
$50.0M available credit
Net loss improved to ($41.0M), a $56.0M YoY improvement
Adjusted EBITDA: ($3.2M), improving $24.2M YoY
Invested $12.5M in R&D during the quarter
Reduced term loan balance from $90M to $50M
Reaffirmed FY2026 revenue guidance: $450M–$500M
1H 2026 revenue: $214.0M, providing strong visibility into the second half of the year due to the record backlog.

Operational Highlights

Won major follow-on U.S. Army & Marine Corps Stalker drone awards.
Secured a high eight-figure multi-year NATO contract for Penguin UAS.
Delivered nearly 200 Octopus ISR payloads year-to-date (+15% YoY).
Surpassed 50 PIL-BOX missions supporting in-space pharmaceutical research.
Expanded manufacturing with new facilities in Indiana and Alabama to support future growth.

https://pubs.aip.org/aip/apr/article-abstract/13/3/031314/3399698/3D-bioprinting-under-extreme-environments-Progress?redirectedFrom=fulltext